Young Talent Group launches actions for young gastroenterologists by introducing the UEG Young GI Network

Por Fichna, Jakub
Publicado em 2014

PhDs in academic gastroenterology: key to a successful career

Por Fichna, Jakub
Publicado no United European Gastroenterol J (2016)

What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine

Por Zatorski, Hubert, Fichna, Jakub
Publicado no Front Med (Lausanne) (2014)

The past, present and future of gastroenterology in Europe and worldwide

Por Fichna, Jakub, Serra, Jordi
Publicado no United European Gastroenterol J (2015)

Young GI angle: The role of bibliometrics in scientist’s career development

Por Zatorski, Hubert, Fichna, Jakub
Publicado no United European Gastroenterol J (2017)

Brain-Gut Interactions in IBS

Por Fichna, Jakub, Storr, Martin A.
Publicado em 2012

Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases

Por Piechota-Polanczyk, Aleksandra, Fichna, Jakub
Publicado em 2014

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation

Por Mosińska, Paula, Fichna, Jakub, Storr, Martin
Publicado no World J Gastroenterol (2015)

The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective

Por Mosińska, Paula, Storr, Martin, Fichna, Jakub
Publicado no Therap Adv Gastroenterol (2015)

Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer

Por Michalak, Arkadiusz, Mosińska, Paula, Fichna, Jakub
Publicado no Front Pharmacol (2016)

The role of morphine in regulation of cancer cell growth

Por Gach, Katarzyna, Wyrębska, Anna, Fichna, Jakub, Janecka, Anna
Publicado em 2011

Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain

Por Chen, Chunqiu, Fichna, Jakub, Laudon, Moshe, Storr, Martin
Publicado em 2014

Role of environmental pollution in irritable bowel syndrome

Por Marynowski, Mateusz, Likońska, Aleksandra, Zatorski, Hubert, Fichna, Jakub
Publicado no World J Gastroenterol (2015)

Dual Functional Capability of Dendritic Cells – Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy

Por Mosińska, Paula, Gabryelska, Agata, Zasada, Malwina, Fichna, Jakub
Publicado no Front Pharmacol (2017)

Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists

Por Mosińska, Paula, Zatorski, Hubert, Storr, Martin, Fichna, Jakub
Publicado no J Neurogastroenterol Motil (2017)

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives

Por Sobczak, Marta, Sałaga, Maciej, Storr, Martin A., Fichna, Jakub
Publicado em 2013

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Por Sobolewska-Włodarczyk, Aleksandra, Włodarczyk, Marcin, Storr, Martin, Fichna, Jakub
Publicado no Ther Clin Risk Manag (2016)

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain - new insights and future perspectives

Por Salaga, Maciej, Storr, Martin, Martemyanov, Kirill A., Fichna, Jakub
Publicado no Bioessays (2016)

Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review

Por Sałaga, Maciej, Zatorski, Hubert, Sobczak, Marta, Chen, Chunqiu, Fichna, Jakub
Publicado em 2014

Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal

Por Fabisiak, Adam, Włodarczyk, Jakub, Fabisiak, Natalia, Storr, Martin, Fichna, Jakub
Publicado no J Neurogastroenterol Motil (2017)